We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Btg Plc | LSE:BTG | London | Ordinary Share | GB0001001592 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 840.00 | 839.00 | 840.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
10/7/2018 15:38 | Looks like CT's prediction of <£4 is not so ridiculous now after all. | spyder | |
10/7/2018 15:37 | Death by a thousand cuts ... This is setting the mood up nicely for next week's meeting. | spyder | |
10/7/2018 15:24 | Truly depressing for shareholders. What are the board doing to arrest this continual weakness? Why aren't they buying shares? If, I were holding now I would be hoping for a takeover. I truly believe Pneumerx is finished, Varithena will have to written down at some point, and CroFab will face serious competition come October. Where is the good news? | cockneytrader | |
10/7/2018 08:48 | Sadly,par for the course.BTG is behaving like Inmarsat.Poor trading performance but smugly continues to pay management eye watering remuneration packages.If you're lucky it presages a bid. | steeplejack | |
08/7/2018 14:07 | At least a large holder is publicly questioning them. Ralf's actions over the years have been very poor for shareholders. Varithena review (from sept) is truly dreadful. They will need to write it down or off (it will never get anywhere near the 'blockbuster' originally billed) as it's not liked, doesn't always work, is expensive, difficult to get insurance money back and is essentially now heavily discounted (only pay for what use) which must screw the revenue model, without accounting for the very low uptake. With all the other issues, fines stuff off patent or generic competition and still a £2bn valuation........ Not quite Shire is it. | waterloo01 | |
08/7/2018 12:29 | Also Louise should be voted down also . | bargainbob | |
08/7/2018 11:15 | They obviously don’t care. | semper vigilans | |
08/7/2018 10:48 | Front page news story in the Sunday Times Business supplement today critical of the company: 'Healthcare boss faces revolt over finance chief pay'. Shareholders adviser ISS has recommended that shareholders vote against BTG's remuneration report at the AGM, as well as voting against the re-election of the chairman Garry Watts. Departed FD Rolf Sodastrom will continue to receive performance based payments until next year. The article also points out that the shares are down 35% this year after 'a series of disappointing product launches'. For the ex-FD to CONTINUE to receive PERFORMANCE BONUSES is absurd in my view for 2 fundamental reasons; 1) if he wanted the bonuses, he should stay. He chose to leave, therefore he forfeits the bonuses - simples! 2) How can anything about the recent PERFORMANCE of the company justify anything resembling a BONUS?! This was a fundamental misstep by the management of BTG who have underestimated the mood of shareholders, and could prove to be a tipping point. This could easily be the CEOs last AGM either because she will be replaced, or the company will be under different ownership in 12 months time. BIG mistake guys..... | spyder | |
06/7/2018 22:17 | Canny, have you asked the company for their comments on this article? | fhmktg | |
06/7/2018 11:37 | Not btg but what a story | cannyshoveyergrannyoffthebus | |
06/7/2018 11:29 | Using google USA and Varithena 2018 gets you to a number of clinic entries in this year, offering V as treatment and pretty good write ups.Hope springs eternal! | fhmktg | |
06/7/2018 11:11 | looking for more on the Phillips tie up , another silent project. Can anyone work with the Dame. | cannyshoveyergrannyoffthebus | |
06/7/2018 07:37 | It's the free cash flow potential in the next 12-24 months that will determine Dame Louise's fate imho.If it keeps on at the current levels or even makes a small headway, then the potential for a mega takeover or merger is possible....who knows even a start of dividend flow....Pray that Varithena has started to kick in some growth with the larger clinics in US and Canada, though I can't find much chat on the web. | fhmktg | |
06/7/2018 06:47 | Re visit the Louise interview on the USA investment show ,to see how far this has fallen against expectations . It much more than 35% given the forecast by the Dame. Anyone going to AGM should ask why do employees have such a low opinion of the management team. | bargainbob | |
05/7/2018 13:11 | if the management cannot give some optimism - why would anyone else invest? | 1oranges | |
05/7/2018 13:01 | Agm 18th July - an indication of optimism would be welcome.Otherwise there may be some harsh words about a 35% slide in the value of the company and no real sustained growth for years. | fhmktg | |
05/7/2018 11:25 | slip sliding away . wake me up when she gone :-) | cannyshoveyergrannyoffthebus | |
04/7/2018 16:26 | It would be good if she was half as good as she thinks she is. | bargainbob | |
04/7/2018 15:43 | Yes that would be nice BUT that hasn’t happened ever to my recall. Nevertheless, I am sure she is totally on our side really! ! | gregmorg | |
04/7/2018 13:51 | Well how about - it would be nice if Louise actually bought some shares instead of having them given to her. | billbailey1 | |
04/7/2018 13:32 | Don’t be silly! | semper vigilans | |
04/7/2018 13:30 | Be nice if Louise actually bought some shares instead of selling | 1oranges | |
04/7/2018 12:07 | Has to rise 1p first . | cannyshoveyergrannyoffthebus |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions